Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1Lymphoma 1Cardiovascular Diseases 1Carcinoma, Hepatocellular 1

Interventions

Exercise 4Cholecalciferol 4Nutrition Assessment 3Gonadotropin-Releasing Hormone 3Blood Pressure 3Atorvastatin 3palbociclib 2acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2acalabrutinib 2Vitamin E 2Social Determinants of Health 2Rosuvastatin Calcium 2Metformin 2Geritol 2Fish Oils 2Fatty Acids, Omega-3 2Ethanol 2Electrocardiography 2Educational Status 2Echocardiography 2Diet, Mediterranean 2Blood Specimen Collection 2Aspirin 2Antineoplastic Agents 2Absorptiometry, Photon 2zanubrutinib 1xinmailong 1ribociclib 1phosphoribosylformylglycinamidine synthetase 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cardiovascular Diseases × Noninvasive Prenatal Testing × Clear all
NCT03051191 2020-10-22

Pathogenic Mechanisms of Cancer and Cardiovascular Diseases

Sakakibara Heart Institute

Completed
66 enrolled

Cardiovascular Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡